Teva Pharmaceuticals
TEVA
TEVA
556 hedge funds and large institutions have $13.7B invested in Teva Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 172 increasing their positions, 170 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
2.94% less ownership
Funds ownership: 65.51% → 62.56% (-2.9%)
13% less funds holding in top 10
Funds holding in top 10: 16 → 14 (-2)
15% less capital invested
Capital invested by funds: $16.2B → $13.7B (-$2.5B)
Holders
556
Holding in Top 10
14
Calls
$596M
Puts
$625M
Top Buyers
| 1 | +$183M | |
| 2 | +$104M | |
| 3 | +$84.5M | |
| 4 |
BMO
Beck Mack & Oliver
New York
|
+$64.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$49.4M |
Top Sellers
| 1 | -$466M | |
| 2 | -$281M | |
| 3 | -$162M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$123M |
| 5 |
Millennium Management
New York
|
-$105M |